PetVivo Holdings, Inc. (PETV)

USD 0.63

(4.99%)

Gross Profit Summary of PetVivo Holdings, Inc.

  • PetVivo Holdings, Inc.'s latest annual gross profit in 2024 was 739.52 Thousand USD , up 89.45% from previous year.
  • PetVivo Holdings, Inc.'s latest quarterly gross profit in 2024 FY was 739.52 Thousand USD , up 89.45% from previous quarter.
  • PetVivo Holdings, Inc. reported a annual gross profit of 390.34 Thousand USD in annual gross profit 2023, up 556.18% from previous year.
  • PetVivo Holdings, Inc. reported a annual gross profit of -85.56 Thousand USD in annual gross profit 2022, down -4644.24% from previous year.
  • PetVivo Holdings, Inc. reported a quarterly gross profit of 34.91 Thousand USD for 2024 Q1, up 47.64% from previous quarter.
  • PetVivo Holdings, Inc. reported a quarterly gross profit of 66.45 Thousand USD for 2024 Q2, up 90.33% from previous quarter.

Annual Gross Profit Chart of PetVivo Holdings, Inc. (2024 - 2011)

Historical Annual Gross Profit of PetVivo Holdings, Inc. (2024 - 2011)

Year Gross Profit Gross Profit Growth
2024 739.52 Thousand USD 89.45%
2023 390.34 Thousand USD 556.18%
2022 -85.56 Thousand USD -4644.24%
2021 1883.00 USD 111.68%
2020 -16.12 Thousand USD 0.0%
2019 - USD 100.0%
2018 -641.87 Thousand USD 13.23%
2017 -739.72 Thousand USD -10.63%
2016 -668.63 Thousand USD 44.37%
2015 -1.2 Million USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%

Peer Gross Profit Comparison of PetVivo Holdings, Inc.

Name Gross Profit Gross Profit Difference
Acutus Medical, Inc. -3.13 Million USD 123.574%
Biotricity, Inc. 8.35 Million USD 91.15%
Cell MedX Corp. - USD -Infinity%
Dynatronics Corporation 7.63 Million USD 90.314%
Nemaura Medical Inc. -1.47 Million USD 150.09%
RetinalGenix Technologies Inc. -100.00 USD 739626.0%
Sonendo, Inc. 10.72 Million USD 93.103%
Telesis Bio, Inc. 16.95 Million USD 95.637%
Talis Biomedical Corporation 371 Thousand USD -99.333%
Viveve Medical, Inc. 620 Thousand USD -19.278%